Summary
The sympathetic nervous system may contribute to excessive hepatic glucose output in Type 2 (non-insulin dependent) diabetes mellitus and could be implicated in the interrelated problem of hypertension. The aim of these studies was to determine whether subjects with Type 2 diabetes had normal sensitivity (compared with age- and weight-matched non-diabetic subjects) to noradrenaline infusion (60 ng · kg−1 · min−1 for 60 min) and to compare the responses with oral tyramine administration (800 mg), and psychological stress (using competitive computer games). Noradrenaline infusion caused significantly greater plasma glucose (mean increment 2.1±0.4 vs 0.6±0.1 mmol/l, p<0.005) and pressor responses (mean systolic increment 21±3 vs 11±1mm Hg, p<0.02) in the diabetic subjects. The excessive glycaemia was due to increased hepatic glucose output rather than reduced glucose disposal. Tyramine administration caused significantly increased hepatic glucose output and plasma glucose levels, but with similar responses in the diabetic and non-diabetic subjects; the pulse and pressor responses were also similar between the groups. The psychological stressor induced significant increases in pulse, blood pressure and non-esterified fatty acid levels in the combined group of subjects (p<0.01) but did not influence plasma glucose levels in either diabetic or non-diabetic subjects. We conclude that pharmacologically-induced sympathetic nervous stimulation can induce hyperglycaemia. Subjects with uncomplicated Type 2 diabetes have increased sensitivity to exogenous noradrenaline but may not hyperrespond to endogenous sympathetic activation.
Article PDF
Similar content being viewed by others
References
Shimazu T (1981) Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 20: 343–356
Lautt WW (1983) Afferent and efferent neural roles in liver function. Prog Neurobiol 21: 323–348
Smythe GA, Grunstein HS, Bradshaw JE, Nicholson MV, Compton PJ (1984) Relationships between brain noradrenergic activity and blood glucose. Nature 308: 65–67
Nobin A, Galck B, Ingemansson S, Jarhult J, Rosengren E (1977) Organisation and function of the sympathetic innervation of human liver. Acta Physiol Scand 452: 103–106
Robertson RP, Halter JB, Porte D Jr (1976) A role for alphaadrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest 57: 791–796
Broadstone VL, Pfeiffer MA, Bajaj V, Stagner JI, Samols E (1987) Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes 36: 932–937
Kashiwagi A, Harano Y, Suzuki M et al. (1986) New alpha2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDMpatients. Diabetes35: 1085–1089
Surwit RS, Feinglos MN (1988) Stress and autonomic nervous system in type II diabetes: a hypothesis. Diabetes Care 11: 83–85
Surwit RS, Feinglos MN (1983) The effects of relaxation on glucose tolerance in non-insulin-dependent diabetes. Diabetes Care 6: 176–179
Feinglos MN, Hastedt P, Surwit RS (1987) Effects of relaxation therapy on patients with type I diabetes mellitus. Diabetes Care 10: 72–75
Kemmer FW, Bisping R, Steingruber HJ (1986) Psychological stress and metabolic control in patients with type I diabetes mellitus. N Engl J Med 314: 1078–1084
Drury PL (1983) Diabetes and arterial hypertension. Diabetologia 24: 1–9
Zavaroni I, Bonora E, Pagliara M et al. (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702–706
Chipps DR, Kraegen EW, Zelenka GS, McNamara ME, Chisholm DJ (1981) Cardiac beat to beat variation: age related changes in the normal population and abnormalities in diabetics. Aust NZ J Med 11: 614–620
McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41: 565–573
Jenkins AB, Furler SM, Chisholm DJ, Kraegen EW (1986) Regulation of hepatic glucose output during exercise by circulating glucose and insulin in humans. Am J Physiol 250: R411-R417
Carroll D, Hewitt JK, Last KA, Turner JR, Sims J (1985) A twin study of cardiac reactivity and its relationship to parental blood pressure. Physiol Behav 34: 103–106
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the state-trait anxiety inventory (self-evaluation questionnaire). Consulting Psychologists Press, Palo Alto
Bruce DG, Storlien LH, Furler SM, Chisholm DJ (1987) Cephalic phase metabolic responses in normal weight adults. Metabolism 36: 721–725
Smythe GA, Duncan MW, Bradshaw JE, Cai WY (1982) Serotoninergic control of growth hormone secretion: hypothalamic dopamine, norepinephrine, and serotonin levels and metabolism in three hyposomatotropic rat models and in normal rats. Endocrinology 110: 376–383
Grunstein HS, Gleeson RM, Smythe GA (1986) Relationship between hypothalamic noradrenergic neuronal activity and serum 3-methoxy-4-hydroxyphenylethylene glycol in the rat. Life Sci 39: 207–213
Hother-Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with type 2 (noninsulin-dependent) diabetes mellitus using primed-continuous 3-3H glucose infusion. Diabetologia 33: 603–610
Carruthers M, Taggart P (1973) Vagotonicity of violence: biochemical and cardiac responses to violent films and television programmes. Br Med J 3: 384–389
Sacca L, Morrone G, Cicala M, Corso G, Ungaro B (1980) Influence of epinephrine, norepinephrine and isoproterenol on glucose homeostasis in normal man. J Clin Endocrinol Metab 50: 680–684
Rizza RA, Cryer PE, Haymond MW, Gerich JE (1980) Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65: 682–689
Rosen SG, Clutter WE, Shah SH, Miller JP, Bier DM, Cryer PE (1983) Direct alpha-adrenergic stimulation of hepatic glucose production in human subjects. Am J Physiol 245: E616-E626
Kawai Y, Powell A, Arinze IJ (1986) Adrenergic receptors in human liver plasma membranes: predominance of beta2- and alpha1-receptor subtypes. J Clin Endocrinol Metab 62: 827–832
De Chatel R, Weidmann P, Flammer J et al. (1977) Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 12: 412–421
Weidmann P, Beretta-Piccoli C, Keusch G et al. (1979) Sodium volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 67: 779–784
Beretta-Piccoli C, Weidmann P (1981) Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus. Am J Med 71: 829–835
Christlieb AR, Janka H, Kraus B et al. (1976) Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 25: 268–274
Scobie IN, Rogers PT, Brown PM, Godfrey H, Sönksen PH (1987) Supersensitivity to both tyramine and noradrenaline in diabetic autonomic neuropathy. J Neurol Neurosurg Psych 50: 275–278
Hilsted J, Richter E, Madsbad S et al. (1987) Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. N Engl J Med 317: 421–426
Pfeiffer MA, Weinberg CR, Cook DL et al. (1984) Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7: 447–453
Izzo JL Jr (1982) Alpha-adrenergic suppression of the sympathetic nervous system and altered norepinephrine kinetic calculations during norepinephrine infusions in man. Clin Res 30: 272A (Abstract)
Garceau D, Yamaguchi N (1982) Pharmacological evidence for the existence of a neuronal amine uptake mechanism in the dog liver in vivo. Can J Physiol Pharmacol 60: 755–762
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I: 785–789
Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA (1983) Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72: 1737–1747
Rouselle J, Buckert A, Pahud P, Jequier E, Felber JP (1982) Relationship between glucose oxidation and glucose tolerance in man. Metabolism 31: 866–870
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bruce, D.G., Chisholm, D.J., Storlien, L.H. et al. The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35, 835–843 (1992). https://doi.org/10.1007/BF00399929
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00399929